NDC product
Retavase
NDC 10122-141 · Chiesi USA, Inc.
Key facts
| Product NDC | 10122-141 |
|---|---|
| Proprietary name | Retavase |
| Labeler | Chiesi USA, Inc. |
| Marketing category | BLA |
| Application number | BLA103786 |
| Marketing start | Oct 30, 1996 |
| Marketing end | Sep 30, 2024 |
| Listing certified through | Sep 30, 2024 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: